Trevi Therapeutics Inc.

NASDAQ: TRVI · Real-Time Price · USD
7.51
0.02 (0.27%)
At close: Aug 15, 2025, 3:59 PM
7.52
0.07%
After-hours: Aug 15, 2025, 04:10 PM EDT

Trevi Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
34.1M 32.4M 12.59M 36.83M
Short-Term Investments
73.53M 50.57M 107.92M n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
243K 297K 205K 334K
Receivables
532K n/a n/a 241K
Inventory
n/a n/a n/a n/a
Other Current Assets
335K 955K 1.31M n/a
Total Current Assets
109.43M 87.55M 122.62M 37.96M
Property-Plant & Equipment
1.23M 1.56M 194K 184K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
1.47M 1.86M 399K 518K
Total Assets
110.9M 89.4M 123.02M 38.48M
Account Payables
3.41M 1.81M 2.86M 2.85M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
285K 306K 7M 5.83M
Other Current Liabilities
2.25M 1.79M n/a 114K
Total Current Liabilities
10.51M 5.82M 13.4M 12.72M
Long-Term Debt
n/a n/a 2.15M 8.65M
Other Long-Term Liabilities
n/a n/a 3K n/a
Total Long-Term Liabilities
747K 1.03M 2.16M 8.68M
Total Liabilities
11.26M 6.86M 15.56M 21.4M
Total Debt
1.03M 1.34M 9.18M 14.63M
Common Stock
94K 68K 60K 29K
Retained Earnings
-287.05M -239.13M -210.07M -180.92M
Comprehensive Income
61K -29K -122K n/a
Shareholders Equity
99.64M 82.55M 107.46M 17.07M
Total Investments
73.53M 50.57M 107.92M n/a